Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24

Trial Status

Terminated4

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT02421354Phase 2Terminated
Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis
HepatomegalyMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+2 more
PrincipalinvestigatorStart date: 2015-05-14
NCT00089388Phase 2Terminated
Cilengitide in Treating Patients With Acute Myeloid Leukemia
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+9 more
Principalinvestigator
NCT00096148Phase 2Terminated
Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+21 more
Principalinvestigator
NCT00387426Phase 2Terminated
Sunitinib in Treating Patients With Idiopathic Myelofibrosis
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+29 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaRecurrent Adult Acute Lymphoblastic LeukemiaRefractory Chronic Lymphocytic Leukemia+30 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Primary MyelofibrosisAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+27 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Refractory Chronic Lymphocytic LeukemiaRecurrent Adult Acute Lymphoblastic LeukemiaRefractory Hairy Cell Leukemia+25 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jorge Cortes

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Recurrent Adult Acute Myeloid LeukemiaBlastic Phase Chronic Myelogenous LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia+20 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score12%

Roger Strair, MD, PhD

Rutgers Cancer Institute of New Jersey

Related
10 trials

Shared therapeutic areas:

Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Guillermo Garcia-Manero

M.D. Anderson Cancer Center

Related
9 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)+8 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score6%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicPrimary MyelofibrosisRecurrent Adult Acute Myeloid Leukemia+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Tapan M Kadia

M.D. Anderson Cancer Center

Related
13 trials

Shared therapeutic areas:

Secondary Acute Myeloid LeukemiaAdult Acute Myeloid Leukemia in RemissionPrimary Myelofibrosis+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Naval Daver, MD

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Leukemia, Myelomonocytic, ChronicMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+1 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Nitin Jain

M.D. Anderson Cancer Center

Related
8 trials

Shared therapeutic areas:

Refractory Chronic Lymphocytic LeukemiaRecurrent Adult Acute Myeloid LeukemiaUntreated Adult Acute Myeloid Leukemia

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02421354Phase 2PrincipalInvestigator

Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis

HepatomegalyMyelofibrosis Transformation in Essential ThrombocythemiaPolycythemia Vera, Post-Polycythemic Myelofibrosis Phase+2 more
Terminated
NCT00089388Phase 2PrincipalInvestigator

Cilengitide in Treating Patients With Acute Myeloid Leukemia

Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+9 more
Terminated
NCT00096148Phase 2PrincipalInvestigator

Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+21 more
Terminated
NCT00387426Phase 2PrincipalInvestigator

Sunitinib in Treating Patients With Idiopathic Myelofibrosis

Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+29 more
Terminated

All 4 trials loaded